ACADIA Pharmaceuticals Inc. vs American Financial Group Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while American Financial Group Inc trades at $144.65 (market cap $11.97B). The key difference: American Financial Group Inc is far larger — about 2.4× ACADIA Pharmaceuticals Inc.'s market cap, and American Financial Group Inc pays a 2.44% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | AFG | |
|---|---|---|
Market Cap | $5.07B | $11.97B |
Sector | Health | Financials |
52-Week High | $29.41 | $148.71 |
52-Week Low | $20.06 | $124.18 |
Enterprise Value | $4.19B | $12.35B |
Dividend Yield | — | 2.44% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. American also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. American's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
Read more on AFG →